Alzheimer’s disease (AD) and cognitive impairment are major global health challenges. Alzheimer’s disease is a progressive neurodegenerative disease that causes severe memory loss, cognitive decline, and eventually loss of independence. Current treatments provide limited symptom relief and do not stop disease progression. Therefore, new treatments are urgently needed. Dihexa, an angiotensin IV (Ang IV) peptide derivative, has emerged as a …